Evidence map›Paper›PMID 42454105›Full record

ArticleComputational and structural biotechnology journal2026

GxP-Ready Single-Cell RNA-seq and Spatial Transcriptomics End-to-End Pipeline for Clinical Research.

Amaya Zaratiegui, Timothy Burfield, Helle Rus Povlsen, Martín E García Solá, Adrian Czaban, Keng Soh, Vivek Das

Abstract read
In one paragraph

Article in Computational and structural biotechnology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Amaya ZaratieguiNovo Nordisk A/S, Søborg, Denmark.
Timothy BurfieldNovo Nordisk A/S, Søborg, Denmark.
Helle Rus PovlsenNovo Nordisk A/S, Søborg, Denmark.
Martín E García SoláZS Associates, ZS Discovery, Buenos Aires, Argentina.
Adrian CzabanNovo Nordisk A/S, Søborg, Denmark.
Keng SohNovo Nordisk A/S, Søborg, Denmark.ORCID https://orcid.org/0000-0003-0908-0169
Vivek DasNovo Nordisk A/S, Søborg, Denmark.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Single-cell/nucleus RNA-sequencing and Spatial Transcriptomics are powerful tools for investigating cellular heterogeneity and tissue architecture that have deepened our disease understanding. Their broader adoption in clinical and regulated settings, however, is hindered by regulatory requirements related to data integrity, regulatory compliance, reproducibility, and scalability. To address this gap, we developed NNclinSSOAP (Novo Nordisk Clinical Single-cell Spatial Omics Analytical Pipeline)-a modular, GxP-ready end-to-end computational pipeline that combines established single-cell workflows with a new Nextflow pipeline for Spatial Transcriptomics. NNclinSSOAP transforms RNA sequencing and Xenium spatial data into integrated, annotated single-cell objects and spatially resolved tissue maps. Designed to support mechanistic studies and clinical endpoint generation, it enables traceable and reproducible processing of large-scale datasets, scalable for use in HPC environments. Here, we provide a step-by-step demo case for using NNclinSSOAP that can be executed within 1.5 h on a standard laptop. All code and data are available open-source.

Identifiers

PMID42454105
PMCPMC13365571

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.